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ABSTRACT
Background Routine third-trimester ultrasound is frequently offered to pregnant women to 
identify fetuses with abnormal growth. Infrequently, a congenital anomaly is incidentally detected.
Objective To establish the prevalence and type of fetal anomalies detected during routine third-
trimester scans using a systematic review and meta-analysis.
Search strategy Electronic databases (MEDLINE, EMBASE, and the Cochrane library) from 
inception until August 2019.
Selection criteria Population-based studies (randomized control trials, prospective and 
retrospective cohorts) reporting abnormalities detected at the routine third-trimester ultrasound 
performed in unselected populations with prior screening. Case reports, case series, case-control 
studies and reviews without original data were excluded.
Data collection and analysis Prevalence and type of anomalies detected in the third trimester. We 
calculated pooled prevalence as the number of anomalies per 1,000 scans with 95% confidence 
intervals (95% CI). Publication bias was assessed.
Main Results The literature search identified 9,594 citations; thirteen studies were eligible 
representing 141,717 women; 643 were diagnosed with an unexpected abnormality. The pooled 
prevalence of a new abnormality diagnosed was 3.68 per 1,000 (95% CI 2.72 - 4.78) women 
scanned. The largest groups of abnormalities were urogenital (55%), central nervous system 
abnormalities (18%) and cardiac abnormalities (14%).
Conclusion Combining data from 13 studies and over 140,000 women, we show that during 
routine third trimester ultrasound, an incidental fetal anomaly will be found in about 1 in 300 
scanned women. This information should be taken into account when consenting women for third 
trimester ultrasound; and when designing and assessing cost of third trimester ultrasound 
screening programs.
Source of Funding
ATP and LD are supported by the National Institute for Health Research (NIHR) Oxford 
Biomedical Research Centre (BRC). The views expressed are those of the author(s) and not 
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INTRODUCTION
Routine third-trimester growth scans in at low-risk women are increasingly recommended with the 
aim of increasing the detection of small for gestational age fetuses, large-for-gestational-age 
fetuses1-4, and breech presentation5, 6, all conditions associated with a higher risk of adverse 
perinatal outcome7-11. Nevertheless, there is an ongoing debate as to whether routine late 
pregnancy ultrasound in low-risk populations confers benefits on the mother or the baby12-15. 
Uncommonly, during a routine third-trimester scan, a previously undiagnosed fetal congenital 
abnormality is detected. Broadly speaking, this includes two separate groups: first, it includes 
congenital defects that were present earlier, but not detected despite adherence to first- and 
second-trimester screening programs; and second, structural abnormalities that develop or 
manifest only in late pregnancy and could not have reasonably been detected earlier. The 
abnormalities included in the first group are those not identified earlier due to unfavourable 
maternal habitus or fetal lie; ones that were overlooked by the screening sonologist; and also 
conditions that may be more easily visualized in a larger fetus, such as a ventricular septal defect 
(VSD). The second group includes abnormalities that can only be seen with fetal maturation, such 
as certain malformations of cortical development, microcephaly or hydrocephaly; gastrointestinal 
abnormalities relating to intestinal obstruction; urinary tract abnormalities that change over time 
such as renal pelvis dilatation; and some skeletal dysplasias.16-20 
There are some important considerations when detecting abnormalities in late pregnancy. These 
include factors at the level of the individual, such as ensuring appropriate consent prior to growth 
scans, anxiety provoked given the limited time to carry out full investigations, and referral for 
appropriate fetal / neonatal care; and implications at the level of the health system, such as the 
need for efficient late referral pathways; associated costs of growth screening In general, even late 
diagnosis of an abnormality will allow parents to prepare for birth of a baby with an anomaly, 
timely in-utero transfer, and guide appropriate follow up of the newborn and infant. 
Because of this, estimating the prevalence of finding such anomalies at the time of the routine 
growth scan is of relevance to patients, practitioners and healthcare providers, as well as 
researchers planning third trimester studies. Data on detection are not well established and are also 
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out only an assessment of fetal growth / amniotic fluid / presentation21 or whether it is intended to 
also formally reassess fetal anatomy22.
The aim of this study was to establish the prevalence and determine the type of malformations 
(chromosomal, genetic, and structural) that are detected at the time of routine third-trimester 
ultrasound screening for fetal growth in populations with adequate prior screening.
METHODS
This is a systematic review and meta-analysis, conducted in accordance with the recommended 
Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and 
the Synthesizing Evidence from Diagnostic Accuracy Tests (SEDATE) guidance23, 24. Patients 
were not involved in the development of this study.
Literature search
The following databases were searched electronically (by the librarian N.W.R) for relevant 
citations, from January 1980 until 28 August 2019: MEDLINE (OvidSP)[1946-present], 
EMBASE(OvidSP)[1974-present], Cochrane Database of Systematic Reviews(Cochrane Library, 
Wiley)[Issue 8 of 12, August 2019], Cochrane Central Register of Controlled Trials(Cochrane 
Library, Wiley)[Issue 8 of 12, August 2019], Database of Abstracts of Reviews of 
Effects(Cochrane Library, Wiley)[issue 2 of 4, April 2015] and Science Citation Index & 
Conference Proceedings Citation Index(Web of Science Core Collection)[1945-present]. The 
search strategy consisted of relevant MeSH terms, keywords and word variants for 'malformation' 
'third-trimester' and 'ultrasound,' restricted to English (Appendix S1). Reference lists of relevant 
articles were searched manually to identify papers not found using the electronic searches. 
Eligibility criteria
We included all population-based studies (randomized control trials, prospective cohort, 
retrospective cohort) that undertook routine third trimester ultrasound. To ensure unbiased results 
which reflect usual practice, we included those studies that reported on unselected pregnant 
populations that had previous ultrasound screening, and that reported on all fetal malformations 
(structural, chromosomal, genetic) identified for the first time at this routine third-trimester 
ultrasound scan. For randomized controlled trials, we included only those women that were in the 
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Studies were excluded if they: (1) did not include a third-trimester scan, or where this was not 
done routinely (the third-trimester scan was recognized as routine only if this was specifically 
acknowledged); (2) reported malformations detected in selected populations, such as in referred 
women, or high-risk pregnancies alone (e.g., in women with gestational diabetes); (3) were case 
reports, case series, case-control studies, and reviews or meta-analyses without original data (4) 
had a policy of no previous second-trimester anomaly screening; (5) did not report both the type 
or and number of malformations found at the third-trimester (6) reported only on malformations of 
a specific system, or having ultrasound scans dedicated to a specific system (such as a study 
assessing only the fetal urinary system). 
Study Selection
Two researchers (L.D and E.B) independently screened the titles and abstracts of all identified 
citations and selected potentially eligible studies. We then retrieved and independently assessed 
these studies for inclusion and data extraction. Discrepancies on assessments of elements or on the 
inclusion of the papers between reviewers were resolved by discussion with A.T.P.
Data Extraction
Data were extracted from each article using a specially designed data-extraction spreadsheet. The 
following data were captured: study characteristics (authors, year of publication, study design, 
healthcare settings, study period), population characteristics (inclusion and exclusion criteria), 
ultrasound scan schedule (first, second, and third-trimester gestational ages), ultrasound scan 
guidelines (scan protocol and checklist of each scan), number of women attending the third-
trimester scan (sample size), malformations detected before the third trimester, at the third 
trimester and after birth (type of malformations included, time of detection, proportion detected), 
as well as detailed information on malformations detected at the third-trimester scan (number 
identified, affected systems, and type of malformations). With respect to the third-trimester scan 
protocol, studies were classified as performing a growth scan (three standard biometric planes), 
following a prespecified anatomy checklist of at least one organ, or performing a repeat detailed 
assessment of the fetal anatomy in a systematic way.
All types of congenital malformations, including structural, genetic, and chromosomal, either 
minor or major, reported in each individual cohort were included in the current analysis. Isolated 
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evidence of a congenital fetal malformation, were beyond the scope of the current analysis. In 
order to reduce the risk of error, all data were collected and extracted from tables independently 
by two authors (L.D and E.B).
Data regarding the number of false-positive diagnoses made in the third-trimester were not 
extracted since for many anomalies it is not possible to distinguish false-positive diagnoses from 
changes due to natural history. 
Quality assessment
Assessment of the quality of the studies included in this review was performed using the Quality 
Assessment of Diagnostic Accuracy Studies (QUADAS-2)25, a tool designed to evaluate the risk 
of bias within each study and assess its applicability to the systematic review. Studies were 
assessed within the four key domains of patient selection, index test, reference standard and flow 
of patients through the study, along with the timing of the index test. A judgment of low, high or 
unclear risk of bias and lack of applicability was made for each study by assessing each domain 
with respect to bias, and the first three domains with respect to applicability, based on a series of 
signaling questions developed specifically to our review (Appendix S2).
Data Analysis
Descriptive tables were produced for study characteristics, ultrasound screening strategy, and 
malformations detected in the third-trimester for the included studies. For each study we 
calculated the prevalence of malformations identified, and the proportion of women attending the 
third-trimester scan where a malformation is detected (and the 95% confidence intervals (95% 
CI)).
The main outcomes were the prevalence and type of anomalies detected at the third trimester 
ultrasound scan. Subgroup analysis by scan period (by decade) was carried out to calculate the 
pooled prevalence in each decade group. Pooled prevalence is expressed as the number of 
anomalies per 1,000 scans with 95% CI. Publication bias was assessed with a funnel plot, and we 
tested for asymmetry in the funnel plot using an unweighted Egger’s test. Statistical analyses were 
carried out in version 3.6.2 of R using the “Meta” and “Metafor” packages to create the analysis 
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Literature identification
The initial search identified 9,594 citations. The full text of 310 manuscripts was reviewed for 
eligibility and 297 were subsequently excluded as they did not meet the selection criteria. Overall, 
13 studies were selected for inclusion in the systematic review21, 22, 26-36 (Figure 1).
Study Characteristics
The studies evaluated were published across four decades, and conducted in China, Europe, India, 
and the USA. Nine out of thirteen studies were single-centre studies, three were two-centre 
studies21, 22, 30 and one was multi-centre27. Of the included studies, there were three randomized 
controlled trials, for which only the screening/third-trimester scan arm was included in the review, 
and there were six prospective studies. Five studies were conducted before 2000. Five studies did 
not offer a first-trimester scan as part of routine care (unclear in one study). A routine second-
trimester scan was an essential part of our inclusion criteria and was therefore carried out for all 
women included in the selected studies. These and other study characteristics are detailed in Table 
1. There were differences in the gestational age of the third-trimester scan, ranging from as early 
as 28 weeks or as late as 40 weeks. In the majority of studies, the third-trimester scan was a repeat 
anomaly scan (7/13 studies). Additionally, there were two studies that specified that they offered a 
growth scan in the third-trimester, and four studies that did not specify the protocol of the third-
trimester scan, i.e., it was not clear whether scans were undertaken only for growth, or also for 
anomaly detection.
Prevalence and type of malformations detected in the third-trimester
In the 13 included studies, a total of 141,717 women underwent a routine third-trimester scan 
(Table 2). The median number of women included per study was 7575 (range 808 – 52,713). In 
these women, a total of 643 fetuses with congenital malformation/s were identified for the first 
time during the third-trimester scan. In the 13 studies, the number of fetal abnormalities detected 
at the third-trimester scan (as a proportion of all fetal abnormalities detected prenatally) varied 
widely, from 0% to 24.8%.
The pooled prevalence of a newly diagnosed malformation at a third-trimester ultrasound was 3.68 
(95% CI 2.72 - 4.78) in 1,000 scans (Figure 2). Sub analysis of the studies by the scan protocol 
revealed that the combined prevalence was 4.20 (95% CI 3.81 – 4.61) per 1,000 scans for the 
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scans for the two studies that specifically mention only conducting a growth scan. In four studies, 
the third-trimester scan protocol was unspecified. Subgroup analysis by scan period (decade) 
showed no significant difference in the prevalence of anomalies (Figure S1).
The overall observed heterogeneity of the included studies in our analysis was high (I2=88%). 
Sensitivity analyses found that the estimated prevalence is not different at a statistically significant 
level (Table S1).
We found that the funnel plot (Figure S2) was statistically asymmetrical at a significant level 
(p=0.0221). This asymmetry does not confirm publication bias, as the distribution on the funnel 
plot is not skewed to the left or the right. Rather, this asymmetry is more likely due to the high 
degree of heterogeneity present in the studies.
Anomalies detected at the routine third-trimester scan are listed in Table S2. Genitourinary 
anomalies were the most common anomaly (54.6%, 351/643). Within urogenital anomalies, renal 
pelvic dilatation was the most common anomaly (57.8%, 203/351), and this condition represented 
roughly 1 in 3 of all abnormalities detected in the third trimester. Central nervous system 
anomalies represented the second most common group of abnormalities (17.6%, 113/643), of 
which the majority were mild/moderate ventriculomegaly (49.6%, 56/113). The third most 
common group was cardiac defects (14%, 90/643).
Methodological quality assessment of included studies
Results of the QUADAS-2 assessment are displayed in Figure S3. With respect to bias in patient 
selection, 9 of the 13 included studies were scored as having a low risk of bias. Four studies were 
deemed to be at high risk of bias owing to failure to provide adequate information regarding 
methods used to enroll patients. With respect to the index test, all studies reported the gestational 
age of the third-trimester scan. Four studies did not specify the third-trimester scanning protocol 
(i.e., growth, repeat anomaly scan, or other) and were therefore considered at high risk of bias. All 
studies were found to be at low risk of bias relating to the reference standard, but it should be 
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In this study, we have shown that in 3.68 (95% CI 2.72 - 4.78) out of 1,000 women with prior 
screening, a previously unrecognized congenital abnormality was diagnosed at a routine third-
trimester scan. Studies that are explicitly designed to address the detection of unexpected fetal 
malformations in the third-trimester are rare. Nevertheless, we were able to identify 13 eligible 
studies reporting previously undetected fetal malformations identified for the first time in the third 
trimester. Of the included studies, seven carried out a repeat anomaly scan in the third-trimester, 
two offered a growth scan only, and the third-trimester scan protocol was not clearly described in 
the remaining four studies.  The prevalence of abnormalities detected in those that undertake a 
growth scan only was 1.5 per 1000 while with repeat anomaly scanning it was 3.8 per 1000. It 
should be noted that these may be lower than or higher when taking into account the confidence 
intervals. In addition, the confidence intervals overlap between these two approaches; 
nevertheless, it is logical that an approach that purposely looks for anomalies will detect more than 
a method where they are truly incidental. 
About half of the identified malformations in late gestation were of the genitourinary system, with 
the majority being renal pelvis dilatation, followed by ovarian cysts, duplex kidney/s, unilateral 
renal agenesis, and polycystic/multicystic kidneys. The second most common system involving 
malformations detected in the third trimester was the central nervous system, in which mainly 
ventriculomegaly/hydrocephalus was the most common. The third most common system involving 
abnormalities was cardiac, in which ventricular septal defect was the most prevalent. 
Strengths and limitations
The present meta‐analysis offers an up‐to‐date, international perspective on newly identified 
anomalies in the third trimester. We ensure that we included different study designs including 
randomized control trials, prospective cohort, retrospective cohort that undertook routine third 
trimester ultrasound from different countries, varying gestational ages, and offering different 
third-trimester scan protocols were analysed. To ensure that we include all relevant studies in the 
current analysis, the search methodology employed was one that yielded a large number of titles. 
During the title read, we encountered many studies designed to assess or report fetal growth in the 
third trimester, however, most often, anomalies were excluded from these studies. In addition, 
relatively few studies were population-based, reporting on the number and type of congenital 
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Limitations of this review include the finding of wide heterogeneity, most likely due to the studies 
being carried out across four decades, from 1979 to 2019, representing different eras in pregnancy 
care. Studies also differed in the third-trimester anatomy checklist, gestational age, and definitions 
(such as the definition of renal pelvis dilatation); it is known that the use and extent of scanning 
protocols may influence detection rates at other gestations37. This needs to be taken into account 
when extending these results to specific populations. Nevertheless, the prevalence of newly 
identified malformations was comparable in most studies. The types of malformations detected 
did differ between studies, with older studies detecting abnormalities that are today commonly 
detected at the second- and even first-trimester scan. It should be noted that in some of the 
included studies ultrasound scans were performed by highly trained individuals using top-quality 
equipment at tertiary centres, and it is likely that less-experienced ultrasound practitioners may not 
be able to replicate these results. In addition, the included studies were in populations where third-
trimester scans are undertaken routinely; in settings where scans are undertaken for clinical 
indications only, many of the abnormalities identified in the included studies would not be 
detected if the fetus is clinically normally grown and a repeat scan is not carried out.
Some studies included were not designed to report third-trimester malformations but included 
these as a part of their results33. This made detection of appropriate studies to be included 
challenging, and there is a possibility that, despite meticulous work carried out by the authors, 
some papers may have been left out. However, the inability to identify all relevant papers is a 
common limitation of meta-analyses, also known as the “drawer effect”38. In addition, English 
language restriction was imposed. Nevertheless, unlike systematic reviews of treatment effect, 
where it is imperative that all evidence is found, our aim was to assess prevalence. Therefore, 
despite these limitations, a large number of pregnancies were included in the analysis, meaning 
confidence intervals around the prevalence estimate are narrow. In addition, prevalence figures 
were comparable between studies, and this further increases the confidence that the results are 
externally valid.
The review does not include analysis of screening characteristics. While this may be seen as a 
limitation, it was an a priori decision. The reason we decided not to report false-positive rates 
(which previous studies have already suggested to be low30, 39) was because our aims were not to 
assess third trimester as a screening test for anomalies, rather to establish how many anomalies 
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ultrasound. Many of the included studies do not report their false-positive and false-negative rates; 
this is partly because “false positives” are not easily defined: for example, hydronephrosis that is 
present on imaging but that resolves cannot be considered as a “false positive”; rather it is a “true 
positive” with a natural history that includes a high chance of spontaneous resolution. False-
negative figures are also difficult to calculate, because detailed post-natal ascertainment of 
abnormalities is usually carried out only if symptoms are apparent. For example, a small 
ventricular septal defect undiagnosed in the third trimester (false negative) may well remain 
undetected after birth in asymptomatic babies, meaning the false negative has become a true 
negative by virtue of not having a reference test. It is for similar reasons that we cannot provide a 
sub-analysis by the severity of anomalies. 
Interpretation
The type and prevalence of abnormalities detected in the third-trimester depend on the scan 
protocol. Currently, there is no internationally agreed policy on whether a third-trimester should be 
routinely offered, nor on what should be included. In England, third-trimester scans are offered 
only to at-risk women, and include serial ultrasound measurement of fetal size and assessment of 
wellbeing with umbilical artery Doppler40. The Australasian Society for Ultrasound in Medicine 
has recently published a third-trimester fetal growth scans reporting template which suggests the 
data-set to be reported; this includes amniotic fluid assessment, basic biometry, umbilical artery PI 
and a "limited anatomy survey within the limits of late gestation, fetal lie, and maternal 
conditions"41. In France, universal third-trimester scan guidelines require a large portion of the 
anomaly scan to be repeated 42. The Società Italiana di Ecografia Ostetrica e Ginecologica e 
Metodologie Biofisiche questions the utility of routine third-trimester scanning. However, if a 
third-trimester scan is performed, the following should be evaluated: four-chamber view, stomach, 
kidneys, and bladder43. In Spain, a third-trimester scan is routinely offered to all pregnant women 
and is limited to the purpose of assessing the amniotic fluid level, fetal presentation, and biometric 
measurements44. In the USA, "Practice Parameter for the Performance of Limited Obstetric 
Ultrasound Examinations by Advanced Clinical Providers" discussing a third-trimester 
examination states that "A limited obstetric ultrasound examination does not include an evaluation 
of fetal anatomy, and in almost all cases, a standard diagnostic or detailed anatomic evaluation of 
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We have shown that half of the abnormalities detected at third-trimester ultrasound are of the 
urogenital system. The majority of these are renal pelvis dilatation which overall represents 1 in 3 
anomalies identified in the third trimester. Previous studies have shown that renal pelvic dilatation 
is a common third-trimester finding with spontaneous postnatal resolution in a large proportion of 
the cases46, 47. The growing kidneys increase in function, produce more urine, and hence 
pathologies not evident previously can be unmasked. This is an example by which a proportion of 
the abnormalities identified in the third trimester may result in maternal anxiety and consumption 
of resources despite being of limited clinical importance. Nevertheless, the diagnosis of 
abnormalities affecting the renal tract is important as it allows postnatal follow up of babies at risk 
of chronic and progressive renal disease before a patient presents with symptoms or deteriorating 
renal function 48. Detection of other abnormalities, in particular those affecting the heart, may 
fundamentally alter the care pathewy for the mother and newborn.
The chance of an incidental finding during a routine third-trimester scan is important for women 
who attend a growth scan; for practitioners; and for policymakers planning resource allocation in 
the context of implementing a protocol of routine growth scanning. The detection of a severe 
structural malformation at any gestational age provokes emotional, moral, ethical and legal 
concerns49, 50. Prenatal counseling should provide information to prospective parents on possible 
interventions, appropriate setting, time and route of delivery as well as the expected postnatal 
outcomes, immediate and long term51. In rare cases, a severe condition that leads to severe 
incurable physical or cognitive disability is diagnosed as late as the third trimester. Here 
management will depend not only on parental personal and religious beliefs but also on the legal 
framework surrounding termination of pregnancy. In some European countries including 
England52, this may be legal at any stage of pregnancy for severe abnormalities53. In many other 
countries, termination of pregnancy is not possible at advanced gestational ages54.
Many studies refer to the “third-trimester” as a uniform term, but it is not a uniform period. Scans 
in the early third-trimester may offer better detection of malformations because the fetal size and 
bone ossification / shadowing do not pose a difficulty, while late third-trimester scans offer a 
better timing for detection of late growth aberrations and malpresentation. Although anomalies 
that occur in late gestation may be more likely to be present, there may also be poorer 









This article is protected by copyright. All rights reserved
scheduled toward the end of the trimester with the aim of detecting growth aberrations, and 
therefore, it is likely that a different subset of anomalies will be identified.
Our findings are also important when designing systems for artificial intelligence that assess third-
trimester biometry. The very low incidence of identifiable abnormalities on the three basic 
biometric planes means that being unable to detect a standard plane is most likely due to an 
acquisition difficulty, rather than a fetal abnormality.
Conclusion
By undertaking an exhaustive review of all relevant studies, we have been able to combine data 
from 13 studies and over 140,000 women. This has demonstrated that during a routine third 
trimester ultrasound scan, an incidental fetal anomaly will be found in about 1 in 300 women, 
despite previous ultrasound screening. The most common anomalies were renal pelvis dilatation 
in a third of cases and other urological anomalies (half of all cases overall); abnormalities of the 
CNS, most often ventriculomegaly; and cardiac defects. This information should be taken into 
account taken by caregivers performing such ultrasound, and women attending such scans should 
be informed of the small possibility of finding an anomaly. The data should also be available to 
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Figure 1 Flowchart of search strategy and selection of studies for inclusion in the systematic 
review
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Table 1 Characteristics of studies reporting on detection of fetal malformations detected at routine population-based third-trimester scans
Authors 
(Publication year)
Study title Study design Population Number of centers Study period Third-trimester scan protocol Third-trimester scan 
gestational age (weeks)
Brocks et al. 
(1991) 26
Routine examination by ultrasound for the detection of fetal 
malformations in a low risk population
Prospective Low risk One 1984-1989 Repeat anomaly 33
Crane et al. (1994) 
27
A randomized trial of prenatal ultrasonographic screening: 
Impact on the detection, management, and outcome of 
anomalous fetuses





Hernádi et al. 
(1997)28
Screening for fetal anomalies in the 12th week of pregnancy 
by transvaginal sonography in an unselected population
Prospective Unselected One 1992-1995 Not stated 30
Eik-Nes et al. 
(2000) 29
Routine ultrasound fetal examination in pregnancy: the 
'Alesund' randomized controlled trial
Randomized trial Unselected One 1979-1981 Growth
(screening group only)
32
Romosan et al. 
(2009) 30
Diagnostic performance of routine ultrasound screening for 
fetal abnormalities in an unselected Swedish population in 
2000-2005
Retrospective Unselected Two 2000-2005 Repeat anomaly 30-34
Abu-Rustum et al. 
(2010)31
Role of first-trimester sonography in the diagnosis of 
aneuploidy and structural fetal anomalies
Retrospective Unclear One 2002-2009 Repeat anomaly 32-35
Manegold et al. 
(2011) 32
Is a routine ultrasound in the third trimester justified? 
Additional fetal anomalies diagnosed after two previous 
unremarkable ultrasound examinations
Prospective Unclear One 1998-2008 Not stated 28-32
Grande et al. 
(2012)33
First-trimester detection of structural abnormalities and the 
role of aneuploidy markers
Prospective Low risk One 2002-2009 Not stated 32-35
Wang et al. 
(2013)34
Ultrasound screening of fetal structural abnormalities by 
standard ultrasound views during the first trimester
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Skråstad et al. 
(2013) 35
A randomized controlled trial of third-trimester routine 
ultrasound in a non-selected population
Randomized trial, 
study group only
Unselected One 1989-1992 Repeat anomaly
(study group only)
33
Vijaykumar et al. 
(2017)36
Detection of structural fetal anomalies in third trimester which 
usually remains undetected in second trimester
Prospective Unclear One unclear Repeat anomaly 24-40
Ficara et al. 
(2020)22
Value of routine ultrasound examination at 35-37 weeks' 
gestation in diagnosis of fetal abnormalities
Prospective Unselected Two 2014-2019 Repeat anomaly 35-37
Drukker et al. 
(2020)21
How often do we incidentally find a fetal abnormality at the 
routine third-trimester growth scan? A population-based study
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Table 2 Number of fetuses affected by malformation(s) according to detection time and prevalence of third-trimester malformations








Prevalence per 1000 scans
(95% Confidence interval)
Abnormalities 
detected after birth 
(number)
Brocks et al. (1991) 26 10752 N/A 24 2.23 (1.42 - 3.22) 0
Crane et al. (1994) 27 7575 31 34 (19.5%) 4.49 (3.10 - 6.13) 109
Hernádi et al. (1997)28 3936 44 10 (15.6%)  2.54 (1.17 - 4.39) 10
Eik-Nes et al. (2000) 29 808 2 0  0 (0.00 - 2.13) 17
Romosan et al. (2009) 30 16775 160 80 (13.9%)  4.77 (3.78 - 5.87) 336
Abu-Rustum et al. (2010)31 1370 34 2 (5.6%)  1.46 (0.02 - 4.39) 0
Manegold et al. (2011) 32 5044 218 44 (15.2%)  8.72 (6.33 - 11.49) 27
Grande et al. (2012)33 13723 N/A 103  7.51 (6.13 - 9.02) Not stated
Wang et al. (2013)34 2822 22 1  0.35 (0 - 1.52) Not stated
Skråstad et al. (2013) 35 3175 22 18 (25.7%)  5.67 (3.32 - 8.61) 30
Vijaykumar et al. (2017)36 10000 N/A 37  3.70 (2.60 - 4.99) 0
Ficara et al. (2020)22 52713 674 247 (24.8%)  4.69 (4.12 - 5.29) 74
Drukker et al. (2020)21 13023 288 43 (9.1%)  3.30 (2.38 - 4.37) 143













Citations identified through search of databases (n= 12303) 
Additional citations identified through 
other sources (n = 184) 
Full-text articles assessed for eligibility (n = 310) 
Excluded (n = 297) 
• No data on third-trimester malformations  
Or third-trimester scan not routine (n = 196) 
• Review, letter, editorial (n = 36) 
• Not a population study (n = 28) 
• Insufficient data (n = 23) 
• Duplicate publication (n = 1) 
• Other (n = 13) 
Included in analysis (n =13) 
References excluded after screening of 
title/abstract (n= 9468) 
References excluded after removing 
duplicates (n= 2709) 
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